First-Line Medication for Nightmares
Prazosin is the first-line pharmacological treatment for nightmares, particularly those associated with PTSD, with the strongest evidence base and Level A recommendation from the American Academy of Sleep Medicine. 1, 2
Prazosin: The Primary Pharmacological Choice
Start prazosin at 1 mg at bedtime and titrate upward by 1-2 mg every few days until nightmares are controlled or side effects emerge. 1, 2
Dosing Strategy
- The average effective dose is approximately 3 mg for civilians with PTSD-associated nightmares 1, 2
- Military veterans with combat-related PTSD typically require higher doses, ranging from 9.5-13.3 mg/day 3, 1, 2
- Maximum recommended dose is 20 mg at bedtime 2, 4
- Therapeutic benefit can occur within one week of initiation 5
Mechanism and Rationale
Prazosin is an alpha-1 adrenergic receptor antagonist that reduces central nervous system sympathetic outflow, directly targeting the elevated noradrenergic activity that drives PTSD-related nightmares and disrupts normal REM sleep. 3, 1
Evidence Base
Three Level 1 randomized placebo-controlled trials demonstrated statistically significant reduction in trauma-related nightmares, with prazosin superior to placebo on the CAPS (Clinician-Administered PTSD Scale) recurrent distressing dreams item. 3, 1
- Treatment duration ranged from 3-9 weeks with maintained improvement 1
- Studies included Vietnam combat veterans, military veterans, and civilian trauma victims 1
Critical Monitoring Requirements
Monitor blood pressure closely due to risk of orthostatic hypotension, the primary adverse effect of prazosin. 1, 2, 6
- Check blood pressure after the first dose and with each dose escalation 7
- Prazosin is otherwise generally well-tolerated across multiple studies 3, 1
Second-Line Pharmacological Options
If prazosin fails or is not tolerated, consider these alternatives in order:
Topiramate
Start at 12.5-25 mg daily and titrate to an effective dose of ≤100 mg/day, which achieves a 79% reduction in nightmares with full suppression in 50% of patients. 1, 2
Trazodone
Use 25-600 mg at bedtime (mean effective dose 212 mg), which reduces nightmare frequency from 3.3 to 1.3 nights per week in 72% of patients. 3, 1, 2
- Common side effects include daytime sedation (60% of patients), dizziness, headache, priapism, and orthostatic hypotension 3, 6
- 19% discontinue due to side effects 3
- Best suited for patients with comorbid insomnia 2
Clonidine
Clonidine 0.2-0.6 mg in divided doses is a Level C alternative, sharing similar mechanism to prazosin but with less rigorous evidence. 3, 1, 6
Medications with Limited Evidence (Level C)
The following may be considered when first and second-line options fail, though data are sparse: 3, 1
- Atypical antipsychotics (olanzapine 10-20 mg, risperidone 0.5-3 mg, aripiprazole) 3, 1
- Nabilone (synthetic cannabinoid): 0.5 mg titrated to maximum 3 mg, reducing CAPS nightmare scores by 3.6 points versus 1.0 for placebo 3, 2
- Gabapentin, phenelzine, low-dose cortisol (10 mg/day), cyproheptadine, tricyclic antidepressants 3, 1
Medications to Avoid
Do not use clonazepam for nightmare disorder—studies show no improvement in frequency or intensity of nightmares compared to placebo. 1, 2, 6
Do not use venlafaxine—it shows no significant difference from placebo in reducing distressing dreams. 1, 2, 6
Avoid nefazodone as first-line therapy due to increased risk of hepatotoxicity. 3, 2
Critical Clinical Considerations
Untreated PTSD-associated nightmares significantly impair quality of life, causing sleep avoidance, sleep deprivation, daytime fatigue, and exacerbation of psychiatric symptoms. 1
Successful treatment with prazosin improves sleep quality, reduces daytime fatigue, and decreases insomnia symptoms. 1
Maintain concurrent psychotherapy and other psychotropic medications during prazosin treatment—prazosin is an adjunctive therapy, not monotherapy. 1, 4
Be aware that SSRIs may significantly reduce prazosin efficacy through drug interactions. 2
Common Pitfall
Do not confuse night terrors with nightmares—night terrors occur during deep non-REM sleep with complete amnesia and require completely different treatment (prazosin has no role), while nightmares occur during REM sleep with full recall. 2